77 related articles for article (PubMed ID: 22129349)
1. Clinical spectrum of atypical fibroxanthoma and undifferentiated pleomorphic sarcoma in solid organ transplant recipients: a collective experience.
McCoppin HH; Christiansen D; Stasko T; Washington C; Martinez JC; Brown MD; Zwald FO
Dermatol Surg; 2012 Feb; 38(2):230-9. PubMed ID: 22129349
[TBL] [Abstract][Full Text] [Related]
2. Pleomorphic Dermal Sarcoma.
Saleh JS; Whittington CP; Bresler SC; Patel RM
Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
[TBL] [Abstract][Full Text] [Related]
3. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patients.
Ørholt M; Abebe K; Rasmussen LE; Aaberg FL; Lindskov LJ; Schmidt G; Wagenblast AL; Petersen MM; Loya AC; Daugaard S; Herly M; Jensen DH; Vester-Glowinski P
J Am Acad Dermatol; 2023 Dec; 89(6):1177-1184. PubMed ID: 37634740
[TBL] [Abstract][Full Text] [Related]
4. Hydrochlorothiazide and increased risk of atypical fibroxanthoma and pleomorphic dermal sarcoma.
Kuntz T; Grimm A; Hofmann SC; Michalowitz AL; Schaller J; Hellmich M; Assaf C; Oellig F; Kreuter A
J Dtsch Dermatol Ges; 2024 Apr; 22(4):513-519. PubMed ID: 38483049
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study.
Salido-Vallejo R; Escribano-Castillo L; Antoñanzas J; Roldán-Córdoba C; Velez A; Aguado-Gil L
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137687
[TBL] [Abstract][Full Text] [Related]
6. Updates in Skin Cancer in Transplant Recipients and Immunosuppressed Patients: Review of the 2022-2023 Scientific Symposium of the International Immunosuppression and Transplant Skin Cancer Collaborative.
Pisano C; Leitenberger JJ; Pugliano-Mauro M; Carroll BT
Transpl Int; 2024; 37():12387. PubMed ID: 38562207
[TBL] [Abstract][Full Text] [Related]
7. Atypical fibroxanthoma in a young woman: An unusual case presentation.
Melendez MM; Xu X; McClain SA; Huang SI
Can J Plast Surg; 2007; 15(3):169-72. PubMed ID: 19554152
[TBL] [Abstract][Full Text] [Related]
8. The Usefulness of Ultrasonography for Supporting the Differentiation, Diagnosis, and Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma.
Crisan D; Schneider LA; Scharffetter-Kochanek K; Bernhard L; Crisan M; Wortsman X
J Ultrasound Med; 2024 May; ():. PubMed ID: 38703399
[TBL] [Abstract][Full Text] [Related]
9. Case Study of Atypical Fibroxanthoma: Presentation and Management.
Woodson J; Baha A; Verma N
Cureus; 2024 Feb; 16(2):e55094. PubMed ID: 38558602
[TBL] [Abstract][Full Text] [Related]
10. Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence".
Ørholt M; Eriksson F; Herly M; Vester-Glowinski P
J Am Acad Dermatol; 2024 May; 90(5):e175-e176. PubMed ID: 38185254
[No Abstract] [Full Text] [Related]
11. More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence.
Pham JP; Staeger R; Frew JW
J Am Acad Dermatol; 2024 May; 90(5):e171-e173. PubMed ID: 38185252
[No Abstract] [Full Text] [Related]
12. Undifferentiated pleomorphic sarcoma in oropharyngeal mucosa of patients with multiple basal cell carcinomas.
Dekanić A; Velepič M; Gobić MB; Hadžisejdić I; Jonjić N
Rare Tumors; 2021; 13():20363613211026483. PubMed ID: 34276919
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
Miller K; Goodlad JR; Brenn T
Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated.
Tardío JC; Pinedo F; Aramburu JA; Suárez-Massa D; Pampín A; Requena L; Santonja C
J Cutan Pathol; 2016 Feb; 43(2):101-12. PubMed ID: 26264237
[TBL] [Abstract][Full Text] [Related]
15. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
16. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T; Aasi SZ; Novoa R; Hollmig ST
Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
[TBL] [Abstract][Full Text] [Related]
17. Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma.
Sun H; Liu J; Hu F; Xu M; Leng A; Jiang F; Chen K
Front Genet; 2023; 14():1109491. PubMed ID: 36873946
[TBL] [Abstract][Full Text] [Related]
18. Lethal Dermal Sarcoma in Immunosuppressed Patients.
Azin M; Ameri AH; Foreman RK; Neel VA; Lorenzo ME; Demehri S
Oncologist; 2022 Sep; 27(9):e759-e761. PubMed ID: 35867136
[TBL] [Abstract][Full Text] [Related]
19. Progression of the atypical fibroxanthoma to pleomorphic dermal sarcoma in a heart transplant patient.
Ripa V; Singh N; Star AE; Smith F
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34215640
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
